HOME_Dental
Acyclonine MUM™
This website is intended for healthcare providers only. Acyclonine MUM™ is a 503B-compounded preparation and has not been approved by the U.S. Food and Drug Administration. Nothing presented herein should be interpreted as a claim of FDA approval or guaranteed outcome.

What is Acyclonine MUM™?

Acyclonine MUM™ is a compounded preparation intended for in-office administration by appropriately licensed healthcare professionals when a compounded preparation is determined to be clinically appropriate.

Acyclonine MUM™ is not FDA approved. FDA has not reviewed it for safety, effectiveness, or quality before marketing.

Acyclonine MUM™ at a Glance

Acyclonine MUM™ uses RAM’s patented dry-powder delivery process for localized intraoral application by a licensed healthcare professional. Product selection, administration, dosing, contraindications, warnings, and monitoring should follow the dispensing pharmacy’s current labeling and the prescriber’s clinical judgment.

The Technology

This preparation is used by spraying medicated powder via bottle actuator onto the lesion or lesions. This medication is for intraoral use only; it is not intended for ophthalmic, nasal or dermatological use.

Warnings

If irritation develops, this medicine should be discontinued. This medication contains a corticosteroid; monitor your patient for HPA axis suppression if prolonged therapy is needed. Do not use if your patient experiences severe or troublesome adverse reactions, becomes pregnant or intends to become pregnant, or breastfeeds.

Precautions

Do not prescribe this medication if your patient has any hypersensitivities to dyclonine, acyclovir, or triamcinolone. Do not use if the patient has an active fungal or bacterial infection of the mouth or throat. A reduced dosage of dyclonine may be required in elderly patients and children.

Potential Adverse Effects

Potential adverse effects associated with the active ingredients and route of administration may include the following. This summary is not exhaustive and does not replace the dispensing pharmacy’s current labeling.
Common:
Temporary burning, stinging, irritation, dryness, redness, soreness, or small mouth ulcers.
Less Common:
Rash or hives, blistering or peeling, delayed healing, or thinning of the oral lining with extended use.
Serious (Discontinue Use):
Allergic reaction (swelling of lips, tongue, or throat; difficulty breathing), severe dizziness or fainting, seizures, or other unusual symptoms such as fatigue, headache, or vision changes.
When to Contact Your Doctor:
If symptoms worsen, do not improve within several days, or if any signs of an allergic reaction occur, stop use and contact your healthcare provider immediately.

Scroll to Top